MoneyWorks4Me

Brooks Laboratories - Quaterly Results

09 Nov 2024 Evaluate
A decrease in the sales to Rs. 207.92 millions was observed for the quarter ended September 2024. The sales stood at Rs. 243.15 millions during the similar quarter previous year.The Company's Net profit for the September 2024 quarter have declined marginally to Rs. 9.55  millions as against Rs. 11.80 millions reported during the corresponding quarter ended.Operating profit for the quarter ended September 2024 decreased to 17.07 millions as compared to 18.08 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 207.92 243.15 -14.49 387.25 400.18 -3.23 794.86 555.38 43.12
Other Income 1.98 0.92 115.22 2.67 1.47 81.63 9.56 1.15 731.30
PBIDT 17.07 18.08 -5.59 20.57 18.88 8.95 41.73 -56.99 -173.22
Interest 3.22 1.87 72.19 4.84 3.58 35.20 8.45 7.67 10.17
PBDT 13.85 16.21 -14.56 15.73 15.30 2.81 33.28 -64.66 -151.47
Depreciation 4.30 4.41 -2.49 8.30 8.82 -5.90 17.73 17.17 3.26
PBT 9.55 11.80 -19.07 7.43 6.48 14.66 15.55 -81.83 -119.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 9.55 11.80 -19.07 7.43 6.48 14.66 15.29 -81.83 -118.69
Equity 262.47 262.47 0.00 262.47 262.47 0.00 262.47 247.03 6.25
PBIDTM(%) 8.21 7.44 10.41 5.31 4.72 12.59 5.25 -10.26 -151.16
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..